Positive DLL3 expression (≥1% tumor cells) correlated with STK11/KEAP1 mutations (characteristic of NSCLC-like LCNEC, as STK11/LKB1 mutations are frequent in NSCLC). This evidence concerns the gene DLL3 and neoplasm.